Resultados: 65

Comment on: Immunotherapy-based firstline treatment of intermediate- and poorrisk advanced renal cell carcinoma: number needed to treat and cost of preventing an event from the perspective of the Brazilian private healthcare system

Leonart, Letícia Paula; Riveros, Bruno Salgado; Berlinski, Felipe; Rego, Maria Aparecida do Carmo.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Imunoterapia, Carcinoma de Células Renais

Texto completo

Analysis of epidemiological and economic data of hemophilia A patients in Brazil

Sarmento, Túlio Tadeu Rocha; Picoli, Renato Mantelli; Renni, Marília; Sato-Kuwabara, Yukie; Mata, Verônica Elizabeth.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Objective: To describe the annual medical direct costs per hemophilia A (HA) patient in the Brazilian public healthcare system (SUS) and to understand and describe the patients’ hospital journey, demographical characteristics, and the procedures in the. Methods: This retrospective analysis of DataSUS d...

Epidemiologia, Hemofilia A, Efeitos Psicossociais da Doença

Texto completo

The cost of total hip replacement: a multicentric TDABC comparison in Brazil

Zanotto, Bruna; Etges, Ana Paula; Sugo, Arthur; Cardoso, Ricardo; Picado, Celso; Nunes, Altacilio; Cruz, Luciane; Lima, Ana Flávia.

J. bras. econ. saúde (Impr.); 14 (Suplemento 2), 2022

Objective: Monitoring costs is critical in searching for a more effective healthcare system. This study aimed to comprehend the care pathway and measure the costs associated with hip replacement surgeries in different hospitals in Brazil. Methods: The time-driven activity-based costing method was applied...

Custos e Análise de Custo, Artroplastia de Quadril, Gastos em Saúde

Texto completo

Analysis of micro-costing through the Time-Driven Activity-Based Costing (TDABC) method in viscosupplementation procedures in different application regimens

Ramos, Leonardo; Cohen, Moisés; Araújo, Denizar.

J. bras. econ. saúde (Impr.); 14 (Suplemento 2), 2022

Objective: To evaluate the micro-costing of viscosupplementation procedures compared to different infiltration regimens. Methods: This study compared, through the Time-Driven ActivityBased Costing method, the micro-costing of these different application regimens using national cost averages as a basis fo...

Alocação de Custos, Osteoartrite, Viscossuplementação

Texto completo

Risk of acute kidney injury and cost-effectiveness analysis comparing vancomycin and linezolid for the treatment of pediatric patients infected with Gram-positive bacteria

Oliveira, Laiane de Jesus; Ricieri, Marinei Campos; Fachi, Mariana Milan; Okumura, Lucas Miyake; Motta, Fábio Araújo.

J. bras. econ. saúde (Impr.); 14 (Suplemento 2), 2022

Objective: This study aimed to compare the occurrence of acute kidney injury (AKI) in pediatric patients who used vancomycin (VAN) or linezolid (LNZ) to treat Gram-positive coccus (GPC) infections and to assess which treatment (VAN or LNZ) is the most cost-effective considering a pediatric hospital persp...

Insuficiência Renal, Vancomicina, Linezolida, 50303, Pediatria

Texto completo

Statements about hemophilia A in Brazil: an expert Delphi panel

Magliano, Carlos Alberto da Silva; Pereira, Ana a Carolina Padula Ribeiro; Fernandes, Roberta Arinelli; Sato-Kuwabara, Yukie; Loze, Priscilla Magalhães; Carlos, Nayara da Silva; Mata, Verónica Elizabeth.

J. bras. econ. saúde (Impr.); 14 (1), 2022

Objective: Understanding unmet needs related to hemophilia A management in Brazil is critical for supporting decision-making. Methods: A modified Delphi consensus panel was conducted. Hematologists with extensive experience treating hemophilia in the Brazilian Public Health System were invited to answer ...

Hemofilia B, Prevenção de Doenças, Terapêutica

Texto completo

Healthcare resource utilization of spinal muscular atrophy in the Brazilian Unified Health System: a retrospective database study

Barbour, Julio; Araújo, Alexandra Prufer de Queiroz Campos; Zanoteli, Edmar; França Junior, Marcondes Cavalcante; Ritter, Alessandra Mileni Versuti; Casarin, Fabiana; Julian, Guilherme Silva; Yazawa, Priscila; Mata, Veronica Elisabeth; Carlos, Nayara da Silva.

J. bras. econ. saúde (Impr.); 13 (2), 2021

Objective: To describe the healthcare resource utilization (HCRU) related to patients with spinal muscular atrophy (SMA) treated at the Brazilian Unified Health System (SUS) since 2015 according to age-groups. Methods: This study analyzed outpatient and inpatient data for SMA patients from the Brazilian ...

Atrofia Muscular Espinal, Sistema Único de Saúde, Doenças Raras

Texto completo (link principal)     Texto completo (link alternativo)    

The use of micro-costing in an economic analysis of allogeneic HSCT in Brazil

Vargas, Dora Fraga; de David, Caroline Nespolo; Horvath, Jaqueline Driemeyer Correia; Silva, Tatiana Schnorr; Pereira, Mariana Pinto; Rigoni, Lisandra Della Costa; Sartor, Ivaine Tais Sauthier; Zavaglia, Gabriela Oliveira; Kern, Luciane Beatriz; Luft, Thainá Dias; Tolves, Fernanda Lutz; Scherer, Fernanda Fetter; Pereira, Jaina da Costa; Barrionuevo, Fabiano; Etges, Ana Paula Beck da Silva; Zanotto, Bruna Stella; Daudt, Liane Esteves; Cruz, Luciane Nascimento; Polanczyk, Carisi Anne; Astigarraga, Claudia Caceres.

J. bras. econ. saúde (Impr.); 13 (2), 2021

Objetivo: O objetivo deste estudo foi estimar os custos do tratamento do transplante de células--tronco hematopoéticas (TCTH) em um centro de referência no Brasil. Métodos: A população do estudo foi composta por pacientes provenientes da lista de TCTH do Sistema Único de Saúde submetidos ao TCTH ...

Custos e Análise de Custo, Transplante de Células-Tronco Hematopoéticas

Texto completo (link principal)     Texto completo (link alternativo)    

Enough with the madness: a systematic review and meta-analysis of hydroxychloroquine for COVID-19

Santos, André Soares; Gonçalves, Érica Sandy Dias; Oliveira, Ananda Jessyla Felix; Lima, Douglas Borges; Noronha, Kenya Valéria Micaela de Souza; Andrade, Mônica Viegas.

J. bras. econ. saúde (Impr.); 13 (2), 2021

Objective: Because of preliminary results from in vitro studies, ydroxychloroquine (HCQ) and chloroquine (CQ) have been proposed as possible treatments for COVID-19, but the clinical evidence is discordant. This study aims to evaluate the safety and efficacy of CQ and HCQ for the treatment of COVID-19. M...

COVID-19, Cloroquina, Hidroxicloroquina, Revisão Sistemática

Texto completo (link principal)     Texto completo (link alternativo)    

Application of the MCDA method for assessing new technologies for familial hypercholesterolaemia treatment

Santos, Marisa da Silva; Morais, Quenia Cristina Dias; Cramer, Helena; Assad, Marcelo; Tura, Bernardo; Santos-Jr, Braulio; Nascimento, Aline do.

J. bras. econ. saúde (Impr.); 13 (1), 2021

Objective: Familial hypercholesterolaemia is a hereditary disease characterized by very high levels of low-density lipoprotein cholesterol and an elevated risk of early-onset cardiovascular disorders. New drugs provide alternatives for the treatment of patients with homozygous familial hypercholesterolae...

Hiperlipoproteinemia Tipo II, Avaliação da Tecnologia Biomédica, Tomada de Decisões

Texto completo (link principal)     Texto completo (link alternativo)